Skip to main content

Advertisement

SpringerLink
Log in

Hypertensive Disorders of Pregnancy and Future Maternal Health: How Can the Evidence Guide Postpartum Management?

  • Preeclampsia (V Garovic, Section Editor)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To review the postpartum management of hypertensive disorders of pregnancy.

Recent Findings

Hypertensive disorders are associated with an increased risk of future cardiovascular disease; however, there is a poor understanding of the underlying mechanisms and few recommendations to guide care in the postpartum period. Recent studies have shown high rates of masked hypertension and home blood pressure monitoring in the first year postpartum may be a promising opportunity to monitor health given evidence of high maternal adherence to this approach. In longer term, women with a history of a hypertensive disorder of pregnancy have higher blood pressures, increased risk of metabolic syndrome, and perhaps excess diastolic dysfunction. Triaging risk and improving handoff from the obstetrician to the primary care provider or subspecialist should be a priority in this population.

Summary

Hypertensive disorders of pregnancy remain an untapped opportunity to identify excess cardiovascular risk in affected women at a time when mitigating that risk during the reproductive years has the potential to improve future pregnancy health as well as improve women’s long-term cardiometabolic health.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol [Internet]. 2019 [cited 2018 Dec 26];133:e1–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30575675.

  2. Hauspurg A, Ying W, Hubel CA, Michos ED, Ouyang P. Adverse pregnancy outcomes and future maternal cardiovascular disease. Clin Cardiol [Internet]. 2018 [cited 2018 Feb 25];41:239–46. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29446836.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Brownfoot FC, Hastie R, Hannan NJ, Cannon P, Tuohey L, Parry LJ, et al. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction. Am J Obstet Gynecol [Internet]. 2016 [cited 2018 Mar 12];214:356.e1-356.e15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26721779.

    Article  PubMed  CAS  Google Scholar 

  4. Costantine MM, Cleary K, Eunice Kennedy Shriver National Institute of Child Health and Human Development Obstetric--Fetal Pharmacology Research Units Network. Pravastatin for the prevention of preeclampsia in high-risk pregnant women. Obstet Gynecol [Internet]. 2013 [cited 2019 mar 9];121:349–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23344286.

  5. Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10.

  6. Bellamy L, Casas J-P, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. Bmj [Internet] 2007;335:974–974. Available from: https://doi.org/10.1136/bmj.39335.385301.BE

    Article  PubMed  PubMed Central  Google Scholar 

  7. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156:918–30.

    Article  PubMed  Google Scholar 

  8. Auger N, Fraser WD, Schnitzer M, Leduc L, Healy-Profitós J, Paradis G. Recurrent pre-eclampsia and subsequent cardiovascular risk. Heart [Internet]. 2017 [cited 2017 Nov 15];103:235–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27530133.

    Article  PubMed  Google Scholar 

  9. Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation [Internet]. 2010 [cited 2018 Jun 25];122:579–84. Available from: http://circ.ahajournals.org/cgi/doi/10.1161/CIRCULATIONAHA.110.943407

  10. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation [Internet]. 2011 [cited 2017 Nov 20];123:2856–69. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21690502.

    Article  PubMed  Google Scholar 

  11. Haug EB, Horn J, Markovitz AR, Fraser A, Klykken B, Dalen H, et al. Association of conventional cardiovascular risk factors with cardiovascular disease after hypertensive disorders of pregnancy: analysis of the Nord-Trøndelag Health Study. JAMA Cardiol [Internet]. 2019 [cited 2019 Sep 6];4:628–35. Available from: https://doi.org/10.1001/jamacardio.2019.1746

    Article  PubMed  PubMed Central  Google Scholar 

  12. Cairns AE, Pealing L, Duffy JMN, Roberts N, Tucker KL, Leeson P, et al. Postpartum management of hypertensive disorders of pregnancy: a systematic review. BMJ Open [Internet]. 2017 [cited 2019 Jun 29];7:e018696. Available from: https://doi.org/10.1136/bmjopen-2017-018696

    Article  PubMed  PubMed Central  Google Scholar 

  13. • Hirshberg A, Downes K, Srinivas S. Comparing standard office-based follow-up with text-based remote monitoring in the management of postpartum hypertension: a randomised clinical trial. BMJ Qual Saf [Internet]. 2018 [cited 2019 Jan 3];27(11):871–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29703800. Summary: Small randomized control trial comparing a text-based remote monitoring protocol for postpartum hypertension compared to usual care in a small cohort of women. They demonstrate increased compliance with having a single blood pressure value recorded in the first ten days postpartum in the text messaging group. Remote hypertension monitoring may improve adherence, improve access to care and may identify women with otherwise unrecognized blood pressure elevations requiring medication in this period, although future study is needed to determine if this improves outcomes in the immediate postpartum period.

  14. ACOG Committee Opinion No. 736 Optimizing Postpartum Care. Obstet Gynecol [Internet]. 2018 [cited 2018 Apr 25];131:e140–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29683911.

  15. Levine LD, Nkonde-Price C, Limaye M, Srinivas SK. Factors associated with postpartum follow-up and persistent hypertension among women with severe preeclampsia. J Perinatol. 2016.

  16. Hoppe KK, Williams M, Thomas N, Zella JB, Drewry A, Kim K, et al. Telehealth with remote blood pressure monitoring for postpartum hypertension: a prospective single-cohort feasibility study. Pregnancy Hypertens [Internet]. 2019 [cited 2019 Apr 10];15:171–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30825917.

    Article  PubMed  Google Scholar 

  17. Hauspurg A, Lemon L, Quinn B, Binstock A, Larkin J. Beigi R, et al. A postpartum remote hypertension monitoring protocol implemented at a hospital level: Obs Gynecol (In Press; 2019.

    Google Scholar 

  18. Smith G, Pudwell J, Saade G. Impact of the New American Hypertension Guidelines on the Prevalence of Postpartum Hypertension. Am J Perinatol [Internet]. 2019 [cited 2018 Sep 6];36:440–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30170330.

  19. • Benschop L, Duvekot JJ, Versmissen J, van Broekhoven V, Steegers EAP, Roeters van Lennep JE. Blood pressure profile 1 year after severe preeclampsia. Hypertension [Internet]. 2018 [cited 2018 Feb 24];71(3):HYPERTENSIONAHA.117.10338. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29437895 Prospective cohort study of women with severe preeclampsia followed one-year postpartum with office and ambulatory blood pressure monitoring. The authors demonstrate that over 40% of women with preeclampsia with severe features had persistent hypertension at one-year postpartum, with 18% of these cases only detected by ambulatory blood pressure monitoring, suggesting that masked hypertension may contribute to increased CV risk in this population.

  20. Hauspurg A, Countouris ME, Jeyabalan A, Hubel CA, Roberts JM, Schwarz EB, et al. Risk of hypertension and abnormal biomarkers in the first year postpartum associated with hypertensive disorders of pregnancy among overweight and obese women. Pregnancy Hypertens [Internet]. 2019 [cited 2019 Mar 9];15:1–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30825904.

    Article  PubMed  Google Scholar 

  21. Veena P, Perivela L, Raghavan SS. Furosemide in postpartum management of severe preeclampsia: a randomized controlled trial. Hypertens Pregnancy Taylor and Francis Ltd. 2017;36:84–9.

    Article  CAS  Google Scholar 

  22. Sharma KJ, Greene N, Kilpatrick SJ. Oral labetalol compared to oral nifedipine for postpartum hypertension: a randomized controlled trial. Hypertens pregnancy [Internet]. 2017 [cited 2019 Aug 26];36:44–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27786578.

  23. ACOG Committee Opinion No. 767 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period. Obstet Gynecol. NLM (Medline); 2019;133:409–12.

  24. Berks D, Hoedjes M, Raat H, Franx A, Looman CWN, Van Oostwaard MF, et al. Feasibility and effectiveness of a lifestyle intervention after complicated pregnancies to improve risk factors for future cardiometabolic disease. Pregnancy Hypertens [Internet]. 2019 [cited 2019 Aug 26];15:98–107. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30825935.

    Article  PubMed  CAS  Google Scholar 

  25. • Cairns AE, Tucker KL, Leeson P, Mackillop LH, Santos M, Velardo C, et al. Self-management of postnatal hypertension: the SNAP-HT trial. Hypertens (Dallas, Tex 1979) [Internet]. 2018 [cited 2018 Nov 1];72(2): 425–432. Available from: https://doi.org/10.1161/HYPERTENSIONAHA.118.10911 This small trial randomized women to systematic titration of anti-hypertensive medications in the postpartum period and demonstrated that this not only shortens the duration of antihypertensive therapy, but also may have a longer-term benefit on blood pressure that persisted up to 6 months postpartum. Currently, there are few guidelines on blood pressure management in this period and if confirmed in larger studies, these findings suggest that blood pressure management in this period may improve longer-term CV outcomes.

    Article  PubMed  CAS  Google Scholar 

  26. Spaan J, Peeters L, Spaanderman M, Brown M. Cardiovascular Risk management after a hypertensive disorder of pregnancy. Hypertension [Internet]. 2012 [cited 2017 Nov 27];60:1368–73. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23071130.

  27. Swan HD, Borshoff DC. Informed consent--recall of risk information following epidural analgesia in labour. Anaesth Intensive Care [Internet]. 1994 [cited 2018 Nov 1];22:139–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8210014.

    Article  PubMed  CAS  Google Scholar 

  28. Brindis CD, Freund KM. The ramifications of recent health policy actions for cardiovascular care of women: progress, threats, and opportunities. Clin Cardiol [Internet]. 2018 [cited 2019 Aug 26];41:173–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29485710.

  29. Porcel J, Feigal C, Poye L, Postma IR, Zeeman GG, Olowoyeye A, et al. Hypertensive disorders of pregnancy and risk of screening positive for posttraumatic stress disorder: a cross-sectional study. Pregnancy Hypertens. Elsevier B.V.; 2013;3:254–60.

    Article  Google Scholar 

  30. Gaugler-Senden IPM, Duivenvoorden HJ, Filius A, De Groot CJM, Steegers EAP, Passchier J. Maternal psychosocial outcome after early onset preeclampsia and preterm birth. J Matern Neonatal Med. 2012;25:272–6.

    Article  Google Scholar 

  31. Sperlich M, Seng JS, Li Y, Taylor J, Bradbury-Jones C. Integrating trauma-informed care into maternity care practice: conceptual and practical issues. J Midwifery Womens Health [Internet]. 2017 [cited 2019 Sep 4];62:661–72. Available from: https://doi.org/10.1111/jmwh.12674

    Article  Google Scholar 

  32. American College of Nurse-Midwives and the National Association of Nurse Practitioners in Women’s Health, American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine, Louis JM, Bryant A, Ramos D, Stuebe A, et al. Interpregnancy care. Am J Obstet Gynecol [Internet]. 2019 [cited 2019 Aug 21];220:B2–18. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30579872.

  33. Celi AC, Seely EW, Wang P, Thomas AM, Wilkins-Haug LE. Caring for women after hypertensive pregnancies and beyond: implementation and integration of a postpartum transition clinic. Matern Child Health J. Springer New York LLC; 2019;

    Article  PubMed  Google Scholar 

  34. Smith GN. The Maternal Health Clinic: improving women’s cardiovascular health. Semin Perinatol [Internet]. 2015 [cited 2017 Nov 27];39:316–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26077232.

    Article  PubMed  Google Scholar 

  35. Cusimano MC, Pudwell J, Roddy M, Cho C-KJ, Smith GN. The maternal health clinic: an initiative for cardiovascular risk identification in women with pregnancy-related complications. Am J Obstet Gynecol [Internet]. 2014 [cited 2017 Nov 27];210:438.e1-438.e9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24316270.

  36. Xie F, Im T, Getahun D. A computerized algorithm to capture patient’s past preeclampsia and eclampsia history from prenatal clinical notes. Health Informatics J [Internet]. 2018 [cited 2019 Sep 4];146045821775424. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29388496.

  37. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. Circulation [Internet]. 2011 [cited 2017 Nov 15];123:1243–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21325087.

  38. Bokslag A, Teunissen PW, Franssen C, van Kesteren F, Kamp O, Ganzevoort W, et al. Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life. Am J Obs Gynecol. 2017;216:523.e1–7.

    Article  Google Scholar 

  39. • Groenhof TKJ, Zoet GA, Franx A, Gansevoort RT, Bots ML, Groen H, et al. Trajectory of cardiovascular risk factors after hypertensive disorders of pregnancy. Hypertension. 2019;73:171–8 Prospective cohort study investigating association of hypertensive disorders of pregnancy and CV risk factor trajectory. Women with a history of hypertensive disorders of pregnancy have higher BP, more antihypertensive medication prescription, and elevated calculated ASCVD risk almost immediately after delivery (age 30s–40s). Some of this risk is attenuated as women approach menopause.

    Article  PubMed  CAS  Google Scholar 

  40. Siu AL. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163:778–86.

    Article  PubMed  Google Scholar 

  41. Whelton PK, Carey RM, Aronow WS, Casey Jr. DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: a report of the American College of Cardiology/American Heart Association Task F. Hypertension [Internet]. 2018;71:1269–324. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29133354.

  42. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Hear J [Internet]. 2018;39:3021–104 Available from: https://www.ncbi.nlm.nih.gov/pubmed/30165516.

    Article  Google Scholar 

  43. Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M, de la Cruz JJ, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med [Internet]. 2018 [cited 2018 Apr 24];378:1509–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29669232.

    Article  PubMed  Google Scholar 

  44. Yang W-Y, Melgarejo JD, Thijs L, Zhang Z-Y, Boggia J, Wei F-F, et al. Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes Association of Office and Ambulatory Blood Pressure With Mortality and CV Outcomes Association of Office and Ambulatory Blood Pressure With Mortality and CV Outcomes. JAMA [Internet]. 2019;322:409–420. Available from: https://doi.org/10.1001/jama.2019.9811.

    Article  PubMed  PubMed Central  Google Scholar 

  45. • Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation [Internet]. 2019;139:e1082–e1143. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30586774 The updated ACC/AHA guidelines on management of blood cholesterol include preeclampsia as a risk factor for CVD and a risk enhancer in decision tree for initiation of a statin for primary prevention in patients at intermediate or high risk to development of CVD.

  46. Miller EC, Boehme AK, Chung NT, Wang SS, Lacey JV Jr, Lakshminarayan K, et al. Aspirin reduces long-term stroke risk in women with prior hypertensive disorders of pregnancy. Neurology [Internet]. 2019;92:e305–16 Available from: https://www.ncbi.nlm.nih.gov/pubmed/30587515.

    Article  CAS  Google Scholar 

  47. Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, et al. The Physical Activity Guidelines for Americans. JAMA [Internet]. 2018;320:2020–8 Available from: https://www.ncbi.nlm.nih.gov/pubmed/30418471.

    Article  Google Scholar 

  48. Rich-Edwards JW, Stuart JJ, Skurnik G, Roche AT, Tsigas E, Fitzmaurice GM, et al. Randomized Trial to Reduce Cardiovascular Risk in Women with Recent Preeclampsia. J Womens Heal [Internet]. 2019/06/20. 2019; Available from: https://www.ncbi.nlm.nih.gov/pubmed/31215837.

  49. Stuart JJ, Tanz LJ, Cook NR, Spiegelman D, Missmer SA, Rimm EB, et al. Hypertensive disorders of pregnancy and 10-year cardiovascular risk prediction. J Am Coll Cardiol [Internet]. 2018;72:1252–63 Available from: https://www.ncbi.nlm.nih.gov/pubmed/30190003.

    Article  Google Scholar 

  50. Markovitz AR, Stuart JJ, Horn J, Williams PL, Rimm EB, Missmer SA, et al. Does pregnancy complication history improve cardiovascular disease risk prediction? Findings from the HUNT study in Norway. Eur Hear J [Internet]. 2019;40:1113–20 Available from: https://www.ncbi.nlm.nih.gov/pubmed/30596987.

    Article  Google Scholar 

  51. Gladstone RA, Pudwell J, Nerenberg KA, Grover SA, Smith GN. Cardiovascular risk assessment and follow-up of women after hypertensive disorders of pregnancy: a prospective cohort study. J Obs Gynaecol can [Internet]. 2019/01/19. 2019;41:1157-1167 e1. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30655227.

    Article  PubMed  Google Scholar 

  52. Castleman JS, Ganapathy R, Taki F, Lip GY, Steeds RP, Kotecha D. Echocardiographic structure and function in hypertensive disorders of pregnancy: a systematic review. Circ Cardiovasc imaging [Internet]. 2016/09/10. 2016;9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27609819.

  53. Vlahovic-Stipac A, Stankic V, Popovic ZB, Putnikovic B, Neskovic AN. Left ventricular function in gestational hypertension: serial echocardiographic study. Am J Hypertens [Internet]. 2010;23:85–91 Available from: https://www.ncbi.nlm.nih.gov/pubmed/19763118.

    Article  Google Scholar 

  54. Rafik Hamad R, Larsson A, Pernow J, Bremme K, Eriksson MJ. Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers. J Hypertens [Internet]. 2009;27:2257–64 Available from: https://www.ncbi.nlm.nih.gov/pubmed/19809366.

    Article  CAS  Google Scholar 

  55. Stewart MH, Lavie CJ, Shah S, Englert J, Gilliland Y, Qamruddin S, et al. Prognostic implications of left ventricular hypertrophy. Prog Cardiovasc Dis [Internet]. 2018 [cited 2019 Sep 6];61:446–55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30408469.

  56. Desai CS, Bartz TM, Gottdiener JS, Lloyd-Jones DM, Gardin JM. Usefulness of left ventricular mass and geometry for determining 10-year prediction of cardiovascular disease in adults aged >65 years (from the Cardiovascular Health Study). Am J Cardiol [Internet]. 2016 [cited 2019 Sep 6];118:684–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27457431.

  57. Melchiorre K, Sutherland GR, Watt-Coote I, Liberati M, Thilaganathan B. Severe myocardial impairment and chamber dysfunction in preterm preeclampsia. Hypertens Pregnancy [Internet]. 2012;31:454–71 Available from: https://www.ncbi.nlm.nih.gov/pubmed/23030711.

    Article  Google Scholar 

  58. Vaught AJ, Kovell LC, Szymanski LM, Mayer SA, Seifert SM, Vaidya D, et al. Acute cardiac effects of severe pre-eclampsia. J Am Coll Cardiol [Internet]. 2018 [cited 2018 Oct 11];72:1–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29957219.

    Article  PubMed  Google Scholar 

  59. • Bokslag A, Franssen C, Alma LJ, Kovacevic I, Kesteren FV, Teunissen PW, et al. Early-onset preeclampsia predisposes to preclinical diastolic left ventricular dysfunction in the fifth decade of life: an observational study. PLoS One [Internet]. 2018;13:e0198908 Available from: https://www.ncbi.nlm.nih.gov/pubmed/29894501 A small observational study showing that a history of preeclampsia is associated with diastolic dysfunction measured by ehcocardiogram parameters in later life.

    Article  CAS  Google Scholar 

  60. Ghossein-Doha C, van Neer J, Wissink B, Breetveld NM, de Windt LJ, van Dijk AP, et al. Pre-eclampsia: an important risk factor for asymptomatic heart failure. Ultrasound Obs Gynecol [Internet]. 2017;49:143–9 Available from: https://www.ncbi.nlm.nih.gov/pubmed/27804179.

    Article  CAS  Google Scholar 

  61. Breetveld NM, Ghossein-Doha C, van Neer J, Sengers M, Geerts L, van Kuijk SMJ, et al. Decreased endothelial function and increased subclinical heart failure in women several years after pre-eclampsia. Ultrasound Obs Gynecol [Internet]. 2018;52:196–204 Available from: https://www.ncbi.nlm.nih.gov/pubmed/28557250.

    Article  CAS  Google Scholar 

  62. Al-Nashi M, Eriksson MJ, Ostlund E, Bremme K, Kahan T. Cardiac structure and function, and ventricular-arterial interaction 11 years following a pregnancy with preeclampsia. J Am Soc Hypertens [Internet]. 2016;10:297–306 Available from: https://www.ncbi.nlm.nih.gov/pubmed/26852291.

    Article  Google Scholar 

  63. Mavrogeni S, Katsi V, Vartela V, Noutsias M, Markousis-Mavrogenis G, Kolovou G, et al. The emerging role of Cardiovascular Magnetic Resonance in the evaluation of hypertensive heart disease. BMC Cardiovasc Disord. 2017;17:132.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  64. Schmieder RE, Wagner F, Mayr M, Delles C, Ott C, Keicher C, et al. The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study. Eur Hear J. 2017;38:3308–17.

    Article  CAS  Google Scholar 

  65. Mohan M, Al-Talabany S, McKinnie A, Mordi IR, Singh JSS, Gandy SJ, et al. A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial. Eur Hear J. 2019/04/18. 2019;

  66. Drazner MH. The progression of hypertensive heart disease. Circulation [Internet]. 2011/01/26. 2011;123:327–34. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21263005.

    Article  PubMed  Google Scholar 

  67. Ersboll AS, Bojer AS, Hauge MG, Johansen M, Damm P, Gustafsson F, et al. Long-term cardiac function after peripartum cardiomyopathy and Preeclampsia: a Danish Nationwide, clinical follow-up study using maximal exercise testing and cardiac magnetic resonance imaging. J Am Hear Assoc [Internet]. 2018/10/30. 2018;7:e008991. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30371259.

  68. Akhter T, Wikstrom AK, Larsson M, Naessen T. Individual common carotid artery wall layer dimensions, but not carotid intima-media thickness, indicate increased cardiovascular risk in women with preeclampsia: an investigation using noninvasive high-frequency ultrasound. Circ Cardiovasc Imaging [Internet]. 2013/07/03. 2013;6:762–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23811751.

    Google Scholar 

  69. Milic NM, Milin-Lazovic J, Weissgerber TL, Trajkovic G, White WM, Garovic VD. Preclinical atherosclerosis at the time of pre-eclamptic pregnancy and up to 10 years postpartum: systematic review and meta-analysis. Ultrasound Obstet Gynecol [Internet]. 2017 [cited 2019 Oct 10];49:110–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27859887.

  70. Cortés YI, Catov JM, Brooks M, El Khoudary SR, Thurston RC, Matthews KA, et al. Pregnancy-related events associated with subclinical cardiovascular disease burden in late midlife: SWAN. Atherosclerosis [Internet]. 2019 [cited 2019 Oct 10];289:27–35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31446211.

  71. McDonald SD, Ray J, Teo K, Jung H, Salehian O, Yusuf S, et al. Measures of cardiovascular risk and subclinical atherosclerosis in a cohort of women with a remote history of preeclampsia. Atherosclerosis [Internet]. 2013;229:234–9 Available from: https://www.ncbi.nlm.nih.gov/pubmed/23664201.

    Article  CAS  Google Scholar 

  72. White WM, Mielke MM, Araoz PA, Lahr BD, Bailey KR, Jayachandran M, et al. A history of preeclampsia is associated with a risk for coronary artery calcification 3 decades later. Am J Obs Gynecol [Internet]. 2016;214:519 e1–8 Available from: https://www.ncbi.nlm.nih.gov/pubmed/26874301.

    Article  Google Scholar 

  73. Zoet GA, Benschop L, Boersma E, Budde RPJ, Fauser BCJM, van der Graaf Y, et al. Prevalence of subclinical coronary artery disease assessed by coronary computed tomography angiography in 45- to 55-year-old women with a history of preeclampsia. Circulation [Internet]. 2018 [cited 2019 Oct 10];137:877–9. Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.032695

    Article  PubMed  Google Scholar 

  74. Wichmann JL, Takx RAP, Nunez JH, Vliegenthart R, Otani K, Litwin SE, et al. Relationship between pregnancy complications and subsequent coronary artery disease assessed by coronary computed tomographic angiography in Black women. Circ Cardiovasc Imaging. 2019;

  75. Benschop L, Schalekamp-Timmermans S, Schelling SJC, Steegers EAP, Roeters van Lennep JE. Early pregnancy cardiovascular health and subclinical atherosclerosis. J Am Hear Assoc [Internet]. 2019;8:e011394. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31331213.

  76. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart Disease and Stroke Statistics-2018 Update: a report from the American Heart Association. Circulation [Internet]. 2018 [cited 2019 Sep 2];137:e67–492. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29386200.

  77. Management of diabetes in pregnancy. Diabetes Care. 2017;40:S114–9.

Download references

Author information

Author notes

  1. Alisse Hauspurg and Malamo E. Countouris contributed equally to this work.

Authors and Affiliations

  1. Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    Alisse Hauspurg & Janet M. Catov

  2. Magee-Womens Research Institute, University of Pittsburgh, 300 Halket Street, Suite 2315, Pittsburgh, PA, 15213, USA

    Alisse Hauspurg & Janet M. Catov

  3. University of Pittsburgh Medical Center Heart and Vascular Institute, Pittsburgh, PA, USA

    Malamo E. Countouris

  4. Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA

    Janet M. Catov

Authors
  1. Alisse Hauspurg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Malamo E. Countouris
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Janet M. Catov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Janet M. Catov.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Preeclampsia

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hauspurg, A., Countouris, M.E. & Catov, J.M. Hypertensive Disorders of Pregnancy and Future Maternal Health: How Can the Evidence Guide Postpartum Management?. Curr Hypertens Rep 21, 96 (2019). https://doi.org/10.1007/s11906-019-0999-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11906-019-0999-7

Keywords

Search

Navigation